SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $202,000 | +47.4% | 1,829 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $137,000 | -17.5% | 1,829 | -13.9% | 0.00% | 0.0% |
| Q1 2022 | $166,000 | -23.5% | 2,124 | -11.1% | 0.00% | 0.0% |
| Q4 2021 | $217,000 | -25.9% | 2,389 | -24.5% | 0.00% | -50.0% |
| Q3 2021 | $293,000 | +7.3% | 3,166 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $273,000 | -75.1% | 3,512 | -76.1% | 0.00% | -71.4% |
| Q1 2021 | $1,096,000 | -55.0% | 14,712 | +2.8% | 0.01% | -58.8% |
| Q4 2020 | $2,436,000 | +5.9% | 14,305 | -12.7% | 0.02% | 0.0% |
| Q3 2020 | $2,300,000 | -19.4% | 16,377 | -8.0% | 0.02% | -26.1% |
| Q2 2020 | $2,855,000 | +33.9% | 17,800 | -18.3% | 0.02% | +109.1% |
| Q1 2020 | $2,132,000 | +46.2% | 21,800 | +92.9% | 0.01% | 0.0% |
| Q4 2019 | $1,458,000 | +321.4% | 11,300 | +145.7% | 0.01% | +266.7% |
| Q3 2019 | $346,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |